Clinical trial
Warfarin and Antiplatelet Vascular Evaluation
NCT00125671 · Anand, Sonia, M.D., Other · Unknown status
Key facts
| NCT number | NCT00125671 |
|---|---|
| Title | Warfarin and Antiplatelet Vascular Evaluation |
| Official title | A Phase III Randomized Trial of Warfarin Plus Antiplatelet Therapy Versus Antiplatelet Therapy Alone in Patients With Peripheral Vascular Disease |
| Lead sponsor | Anand, Sonia, M.D., Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Heart and Stroke Foundation of Ontario |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Peripheral Vascular Diseases, Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | Warfarin |
| Enrollment | 2,400 |
| Start date | Jan 1, 2000 |
| Completion | Apr 1, 2006 |
| First posted | Aug 1, 2005 |
| Last update posted | Sep 29, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: